Credit ratings agency India Ratings and Research (Ind-Ra) assigned Jubilant Ingrevia (JVL) a long-term issuer rating of 'IND AA' with a stable outlook.
The ratings agency assigned a credit rating of 'IND AA/Stable/IND A1+' on the company's fund-based limits of Rs 475 crore. It has assigned 'IND A1+' rating on the non-fund-based limits of the company worth Rs 772.5 crore.India Ratings and Research said that it has taken a consolidated view of JVL and its wholly-owned subsidiaries Jubilant Infrastructure ('IND A-'/Stable), Jubilant Lifesciences International, Jubilant Lifesciences NV, Jubilant Lifesciences USA Inc. and Jubilant Lifesciences Shanghai to arrive at the ratings, given the strong operational and strategic ties among them.
Effective 1 February 2021, the life science ingredients (LSI) business of Jubilant Life Sciences was demerged to JVL. The demerger was carried out to create separate and focused entities for the pharma and LSI businesses to unlock shareholder value and generate greater operational efficiencies, along with a dedicated management structure. JVL's business comprises specialty chemicals (SC; 34% of 9MFY21 sales;), nutrition and Health solutions (NP; 18%;) and life science chemicals (LSC; 48%;) businesses.
JVL has presence across three segments in SC, nutrition and health solutions and LSC, with healthy levels of backward integration and a leading market position. The ratings factor in the healthy balance sheet post business carve out of pharma business with JVL holding only long-term debt, which is not significant.
JVL is an integrated life science products company and provides innovative solutions to pharmaceutical, nutrition, agrochemical, consumer and industrial customers. The company's portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. The company has five manufacturing facilities located in Gujarat, Maharashtra and Uttar Pradesh.
The scrip jumped 9.51% to end at Rs 571.85 on Friday.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
